HIV prevention drug lenacapavir approved by FDA as twice …
1 day ago · The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained …
FDA approves twice-a-year injection for HIV prevention - CNN
1 day ago · A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. …
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV ...
1 day ago · Individuals must be tested for HIV-1 infection prior to initiating Yeztugo, and with each subsequent injection of Yeztugo, using a test approved or cleared by the FDA for the …
FDA approves new twice-yearly HIV shot in bid to end epidemic
1 day ago · The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new …
HIV prevention drug hailed as a 'breakthrough' gets FDA approval
1 day ago · A pharmacist holds a vial of lenacapavir, the injectable drug that prevents HIV infection. On June 18, the FDA approved the drug for use in the U.S. Nardus Engelbrecht/AP …
FDA Approves First Twice-Yearly Shot to Prevent HIV - WebMD
1 day ago · Gilead, the drug's maker, said the FDA approved Yeztugo based on two major studies, which showed that it worked better than taking a daily pill form of PrEP in preventing …
Gilead Sciences Lands First FDA Approval of a Twice-a-Year HIV PrEP Drug
1 day ago · A Gilead Sciences drug that protects against HIV infection has won a highly anticipated FDA approval, becoming the first medication for HIV prevention available as a …
FDA approves Gilead HIV prevention injection lenacapavir
2 days ago · The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.
Regulators Approve Lenacapavir for H.I.V. Prevention
1 day ago · The approval is among the most anticipated developments in the prevention of H.I.V. But it arrives during deep cuts to global health programs that were expected to purchase and …
FDA Approves a Twice-Yearly Shot to Prevent HIV - TIME
1 day ago · Lenacapavir was approved by the FDA in 2022 to treat people with HIV whose virus has become resistant to other antiviral drugs. As they were developing that treatment, Gilead’s …